Health knowledge made personal
WellPage for Her-2-negative
+ Bookmark › Share
Go
Search posts:

Her-2-negative - Articles

Mainenance Avastin for breast cancer by Mark Levin Posted Wed 24 Jun 2009 7:01pm The AVADO trial was a Phase III, double-blind, placebo-controlled trial comparing the combination of Avastin and Taxotere to Taxotere alone in locally recurrent or metastatic breast cancer.  Patients with locally recurrent or metastatic, HER2-negative breast cancer were randomized to Taxotere (100 mg/m2 every three weeks for up to nine cycles) ... Read on »
On Friday, we posted a press rel ... by Prescription Access Litigation Patient ExpertHealth Maven Posted Thu 30 Oct 2008 3:21pm On Friday, we posted a press release from Breast Cancer Action ( Breast Cancer Action: Patients Lose, Genentech Wins with FDA’s Avastin Ruling ) criticizing the FDA’s approval of Genentech’s [NYSE:DNA] Avastin for treatment of metastatic breast cancer. We noted that it was odd that the FDA approved this drug, given that the Oncologic Drugs ... Read on »
FDA Grants Genentech (Roche) a Hearing on Avastin ’s Use for Metastatic Breast Cancer by Medical Quack Patient ExpertHealth Maven Posted Fri 25 Feb 2011 2:57am The date for the hearing is a few months off and until that time the drug is still approved as a first line treatment of the HER2 Negative mBC (breast cancer).  Genentech filed the request for a formal hearing and the opportunity to present additional documentation to support continued use for treating women with metastatic breast cancer. BD ... Read on »
FDA Approves New Drug for Breast Cancer Afinitor from Novartis That Is Already Approved for Treating Kidney and Other Cancers by Medical Quack Patient ExpertHealth Maven Posted Fri 20 Jul 2012 8:37pm The drug is designed to be given in coordination with another drug Aromasin which is made by Pfizer.  This sounds like a good bit of research here to find the drug effective for breast cancer.  There are quite a few side effects listed on the website.   The drug is also used to treat pancreas cancer.  The good news too is that it is a pill so t ... Read on »
Soy reduces breast cancer risk b... by Dr. Rubens D. Medical Doctor Posted Thu 16 Oct 2008 7:56pm Soy reduces breast cancer risk by receptor status 17 oct 2008--Rather than protecting against all breast cancers, high levels of soy food consumption appears to specifically reduce the risk of estrogen receptor (ER)-positive tumors and human epidermal growth factor receptor 2 (HER2)-negative tumors, Japanese researchers report in the Internatio ... Read on »
When Combined with Chemo, Bevacizumab Is Associated with an Increased Risk of Death by Cancer.gov Posted Sun 27 Feb 2011 10:35pm When Combined with Chemo, Bevacizumab Is Associated with Increased Risk of Death Tumors release the protein VEGF (pictured above next to the tumor in gray) as a signal to recruit the growth of nearby blood vessels, so that they can establish their own nutrient supply. Bevacizumab (pictured above as green and pu ... Read on »
The FDA granted accelerated appr... by Sally N. Patient ExpertHealth Maven Posted Sun 28 Sep 2008 7:42pm The FDA granted accelerated approval for the drug Avastin in combination with paclitaxel chemotherapy for breast cancer patients. The approval comes after a study that showed a combination of Avastin resulted in a 52 percent reduction in the risk of disease progression or death compared to those treated with paclitaxel chemo alone. Why is thi ... Read on »
PAL coalition memberBreast Cance ... by Prescription Access Litigation Patient ExpertHealth Maven Posted Thu 30 Oct 2008 3:21pm PAL coalition member Breast Cancer Action today lambasted the FDA’s decision to grant accelerated approval for Avastin® (bevacizumab), in combination with paclitaxel chemotherapy, for the treatment of patients who have not received chemotherapy for their metastatic HER2-negative breast cancer. Back in December, Breast Cancer Action had app ... Read on »
Risk of HER2-Positive Breast Cancer Recurrence by Aaron Tabor Medical Doctor Posted Fri 06 Nov 2009 12:00am About 20% of breast cancer patients have tumors that over-express the human epidermal growth factor receptor 2 (HER2), a characteristic that has been associated with lower breast cancer survival rates.  For these breast cancer patients, treatment with the drug Herceptin has provided substantial improvements in breast cancer recovery.  However, m ... Read on »
How to Spot the Different Types of Breast Cancer by PinkRibbons .. Posted Sun 24 Aug 2008 1:49pm ANNOUNCER: Upon an initial diagnosis, physicians test breast cancer for certain qualities that help them decide on treatment. One of the key things that physicians are interested in is a cancer's HER2 status. Although physicians don't fully understand how the HER2 gene works, it is known that proteins regulated by the HER2 gene help control cell gr ... Read on »